Chronic myeloid leukemia: A disease of youth in Brazil

Leukemia Research

Volumn 34, Issue 4, 2010, Pages 542-544

  de Campos, Mireille Guimarães Vaz ^a   Arantes, Adriano de Moraes ^a   de Oliveira, José Salvador Rodrigues ^a   Chauffaille, Maria de Lourdes Lopes Ferrari ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENETIC POLYMORPHISM; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; JUVENILE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 76949097258     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.09.008     Document Type: Article

References (7)

1. Cervantes F., Hernandez-Boluda J.C., Ferrer A., Cid J., and Montserrat E. The changing profile of Ph-positive chronic myeloid leukemia at presentation: possible impact of earlier diagnosis on survival. Haematologica 84 4 (1999) 324-327
2. Cortes J., Talpaz M., O'Brien S., Giles F., Beth Rios M., Shan J., et al. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer 98 6 (2003) 1105-1113
3. Braga G.V., Chauffaille M.L.L.F., Moncau J.E.C., Souto E.X., Silva M.R., and Kerbauy J. CML: prognostic factors and survival analysis. SPMJ 114 1 (1996) 1083-1090
4. Ruiz M.A. Revista Brasileira de Hematologia e Hemoterapia - Anais do Congresso Brasileiro de Hematologia e Hemoterapia - Hemo2005. Rev Bras Hematol Hemot 27 2 (2005) 130-139 [abstracts 358, 365, 374, 375, 377, 352]
5. Mukiibi J.M., Nyirenda C.M., Paul B., Adewuyi J.O., Mzula E.L., and Malata H.N. Chronic myeloid leukaemia in central Africans. East Afr Med J 80 9 (2003) 470-475
6. Deshmukh C., Saikia T., Bakshi A., Amare-Kadam P., Baisane C., and Parikh P. Imatinib mesylate in chronic myeloid leukemia: a prospective single arm. Non-randomized study. J Assoc Physicians India 53 (2005) 291-295
7. Syed N.N., Usman M., Khaliq G., Adil S.N., and Khurshid M. Clinico-pathologic features of chronic myeloid leukemia and risk stratification according to Sokal score. J Coll Physicians Surg Pak 16 5 (2006) 336-339